Tagged with Pharma,

Serbia Marija Krstic, general manager of GSK Serbia and Montenegro, discusses how the various positions she has undertaken during her 13-year career at GSK help inform her current role, the initiatives that GSK Serbia is involved in to increase access to innovative medicines for Serbian patients, and her push to ensure…

Serbia Predrag Bogavac, now Country Head, OGM Serbia and Montenegro, a.i. Oncology General Manager Bulgaria and Macedonia at Novartis, shares the highlights of the past two years as Country Head of Novartis Serbia and Montenegro, his responsibilities as Head of Oncology, the challenges within the Serbian market, particularly surrounding reimbursement, and…

Brazil Poul Sorensen, director of Geistlich Pharma in Brazil, details the importance of educational activities for Geistlich’s business, the affiliate’s desire to bring new segments of Geistlich’s portfolio to Brazil and the necessity of adapting the business strategy to each region in Brazil according to their price sensitivity. Could you introduce…

Brazil Jun Eguti, general manager of Grünenthal Brazil, highlights the global transformation Grünenthal has undergone in the past two years, the huge potential the Brazilian affiliate has to become one of the largest in LatAm and the exciting product pipeline the affiliate has in Pain Management, Women’s Health, CNS and Gout…

Brazil Alexei Kolchin, general manager of GSK Brazil, discusses adapting to Brazil, having previously held the equivalent role in Russia, the Brazilian affiliate’s contribution to GSK’s global growth, and its embrace of digitally disruptive technologies. Before being appointed GM of GSK in Brazil, you were the GM for GSK Russia, so…

India A passionate advocate for Indian patients, Sanjiv Navangul, managing director of Janssen India, discusses the company’s public health work in the field of tuberculosis (TB) and multi-drug resistant TB (MDR-TB) in support of the Government of India’s efforts to end TB, including providing access to novel drug bedaquiline, initiating a…

India A strong advocate for quality, Dilip Surana, chairman and managing director of Micro Labs, explains how the company’s strong focus on the quality of its products and move to specialty generics has led them to success in both the Indian and US markets. When we met in 2011, the company…

Serbia Nenad Markovic, director of fast-growing, family-run pharmaceutical company ADOC in Serbia, sheds light on the organisation’s rapid and consistent growth, the ADOC stamp of approval and why the road to EU membership will be a smooth one for ADOC. What are ADOC’s current operations in Serbia? “We are very happy…

Canada Dr. David Goodman, CEO of Pharmascience, talks about the strategy for the international expansion of the company, key for which are long-lasting partnerships. He also analyzes the re-organization of the company amongst the two main axes of generics and branded products and highlights its dedication to R&D, especially in the…

Poland Michał Mieszkowski, general manager of Angelini Poland, discusses the strategic significance of Poland for the company, as the third largest affiliate within the global company, the company’s impressive product portfolio and exciting pipeline, new therapeutic areas, and his future aspirations for Angelini Poland. As the general manager for Poland at…

Switzerland Dr. Teodoro Albarano, chief medical officer and vice CEO of Swiss skincare specialists Mavena, discusses why he decided to join the company after an illustrious career in Big Pharma, Mavena’s internationalization activities, and the importance of effective treatments for psoriasis.   You decided to join Mavena a year ago after…

Serbia Claude Broudic, general manager for Servier in Serbia, highlights the potential for business in the country, Servier’s projects for expansion in the Balkans, and the skills needed to put together a good pharma team. What were your priorities when you took over as general manager of Servier Serbia? “When looking…